Advertisement

Topics

Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

16:15 EST 15 Feb 2018 | Reuters

(Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held U.S. cancer data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patient...

Original Article: Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

NEXT ARTICLE

More From BioPortfolio on "Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...